Cardiology/Medicine, Wexham Park Hospital, Frimley Health NHS Foundation Trust, Slough, UK.
Cardiology/Medicine, Royal Free Hampstead NHS Trust, London, UK.
Eur J Hosp Pharm. 2022 Nov;29(6):336-339. doi: 10.1136/ejhpharm-2020-002603. Epub 2021 Feb 24.
Drug-related bradycardia (DRB) is a common clinical conundrum and can result in multiple hospital admissions as a result of the increased prescription of rate-limiting medications that can predispose to presyncopal or syncopal episodes.
To evaluate the incidence of DRB in elderly hospital inpatients.
We conducted a retrospective analysis of all patients admitted to our acute medical unit between November 2018 and February 2019 and identified patients over the age of 70 with more than one diurnal bradycardic episode during their admission. We extracted patient demographics, presenting complaint, admission 12-lead ECG and medications from the hospital electronic database.
We screened 2312 adults and identified 100 patients over the age of 70 years with two or more episodes of diurnal bradycardia during their hospital admission. This constituted 4.32% of total admissions. Beta blockers were the most commonly prescribed rate-limiting medication (n=54, 87.1%), of which bisoprolol was the most frequently prescribed (n=41) and sinus bradycardia was the most commonly identified rhythm disturbance in our cohort of patients (n=41, 41%). Syncope was the most common presenting symptom and occurred in 23 patients, 14 (60.9%) of which were diagnosed with a DRB. Atrial fibrillation was more common in those with DRB compared with those with bradycardia not caused by medications (35.5% vs 10.5%, p=0.006), and atrial fibrillation was a significant predictor of DRB (OR=10.2, 95% CI 3.3 to 31.6, p<0.001).
Bradycardia is a significant cause of hospital admissions in older adults and can be avoided with pharmacovigilance. Caution should be exercised when initiating or changing the dose of rate-limiting agents in these patients; while those with atrial fibrillation should undergo regular review of their heart rate followed by appropriate medication dose adjustments.
药物相关性心动过缓(DRB)是一种常见的临床难题,由于限速药物的处方增加,导致预晕厥或晕厥发作的可能性增加,从而导致多次住院。
评估老年住院患者中 DRB 的发生率。
我们对 2018 年 11 月至 2019 年 2 月期间入住我院急性内科病房的所有患者进行了回顾性分析,并确定了年龄在 70 岁以上且在住院期间有两次以上白昼心动过缓发作的患者。我们从医院电子数据库中提取了患者的人口统计学、就诊症状、入院 12 导联心电图和药物使用情况。
我们筛选了 2312 名成年人,发现 100 名年龄在 70 岁以上的患者在住院期间有两次或两次以上的白昼心动过缓发作。这占总入院人数的 4.32%。β受体阻滞剂是最常用的限速药物(n=54,87.1%),其中比索洛尔使用最频繁(n=41),窦性心动过缓是我们患者队列中最常见的节律紊乱(n=41,41%)。晕厥是最常见的就诊症状,发生在 23 名患者中,其中 14 名(60.9%)被诊断为 DRB。与非药物引起的心动过缓相比,DRB 患者中房颤更为常见(35.5%比 10.5%,p=0.006),房颤是 DRB 的一个显著预测因素(OR=10.2,95%CI 3.3 至 31.6,p<0.001)。
心动过缓是老年患者住院的一个重要原因,可以通过药物警戒来避免。在这些患者中开始或改变限速药物的剂量时应谨慎;对于那些有房颤的患者,应定期检查心率,然后进行适当的药物剂量调整。